Cargando…
E‐REVEAL Lite 2.0 scoring for early prediction of disease progression in pulmonary arterial hypertension
Risk stratification is an essential tool in the management of pulmonary arterial hypertension (PAH). These tools lack detailed echocardiographic assessment which plays a central role in clinical risk assessment in PAH. Thus, we aimed at assessing whether adding echocardiography‐driven data to REVEAL...
Autores principales: | Sahay, Sandeep, Bhatt, Jiken, Beshay, Sarah, Guha, Ashrith, Nguyen, Duc T., Graviss, Edward A., Nagueh, Sherif F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052981/ https://www.ncbi.nlm.nih.gov/pubmed/35506081 http://dx.doi.org/10.1002/pul2.12026 |
Ejemplares similares
-
Evaluation, Diagnosis, and Classification of Pulmonary
Hypertension
por: Sarah, Beshay, et al.
Publicado: (2021) -
Insights and Advances in the Diagnosis, Treatment, and Management of
Pulmonary Hypertension
por: Guha, Ashrith, et al.
Publicado: (2021) -
Drs. Sandeep Sahay and Ashrith Guha Lead Issue on Pulmonary
Hypertension
por: Sahay, Sandeep, et al.
Publicado: (2021) -
Real-world experience using combination therapy with riociguat and
risk assessment using REVEAL Lite 2.0 in patients with pulmonary arterial
hypertension
por: Sahay, Sandeep, et al.
Publicado: (2020) -
Management of pulmonary hypertension associated with valvular heart disease with angiotensin‐receptor neprilysin inhibitor
por: Ali, Hyeon‐Ju Ryoo, et al.
Publicado: (2023)